5125292026-06-085125292026-06-082026-06-08iso4217:INRxbrli:pure512529VIYASH SCIENTIFIC LIMITEDVIYASHNOTLISTEDINE807F01027NewAcquisition (including agreement to acquire)false2026-06-0812:07:002026-06-08Alivira Animal Health Limited, IrelandStep Down SubsidiaryBioForLife Italia s.r.l.913000000135900000207400000falsefalsetruePharmaceuticals- Animal Health / Veterinary Products-Companion AnimalThe acquisition is intended to strengthen and scale the Company’s presence in Italy in the companion animal segment through an established front-end platform, customer reach and product capabilities.YesNotification under Italian Golden Power Laws (Decree-Law No. 21/2012)trueInitial closing is expected within 3 months from execution of the binding agreement, subject to fulfilment of conditions precedent. Deferred consideration, if payable, is expected to be settled in accordance with the transaction documents within 12 months from closing or earlier upon occurrence of the relevant trigger.Cash1880000000Aggregate consideration of EUR 16.975 million, comprising EUR 15.0 million payable at closing and EUR 1.975 million as deferred consideration, subject to the terms of the transaction documents and customary adjustments as applicable.1880000000011BioForLife Italia s.r.l is a Company based in Milan, Italy and engaged in marketing and distribution of products for Veterinary use, almost entirely in Italy. The products include medicines, nutraceuticals and testing kits.2010-03-24ItalyTurnover, PAT, Networth are based on exchange rate euro to inr as on 31.12. 2025